Commentary: On Drummond’s “Time for a change in drug licensing requirements?”

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.3, Iss.2, 2002-06, pp. : 138-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Commentary: On Drummond’s “Time for a change in drug licensing requirements?”

By Jönsson Bengt

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 139-139

Springer Publishing Company

Access to resources Recommend Favorite

Drug licensing requirements are changing!: Comment on Drummond’s short paper

By Lekkerkerker F. Rutten F.

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 141-142

Springer Publishing Company

Access to resources Recommend Favorite

Time for a change in drug licensing requirements?

By Drummond Michael F.

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite

Time for a change in drug pricing : Going downstream: Comment on Drummond’s short paper

By Pouvourville Gérard

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 140-141

Springer Publishing Company

Access to resources Recommend Favorite

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 426-437

John Wiley & Sons Inc

Access to resources Recommend Favorite